These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23379575)

  • 1. T and NK cells: two sides of tumor immunoevasion.
    Fruci D; Lo Monaco E; Cifaldi L; Locatelli F; Tremante E; Benevolo M; Giacomini P
    J Transl Med; 2013 Feb; 11():30. PubMed ID: 23379575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
    Campoli M; Ferrone S
    Tissue Antigens; 2008 Oct; 72(4):321-34. PubMed ID: 18700879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
    Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC
    Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Natural Killer and CD8
    Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
    Smits NC; Coupet TA; Godbersen C; Sentman CL
    Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.
    Rosental B; Appel MY; Yossef R; Hadad U; Brusilovsky M; Porgador A
    Curr Med Chem; 2012; 19(12):1780-91. PubMed ID: 22414084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The innate immune response to tumors and its role in the induction of T-cell immunity.
    Diefenbach A; Raulet DH
    Immunol Rev; 2002 Oct; 188():9-21. PubMed ID: 12445277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C; Zhang J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bird's eye view of NK cell receptor interactions with their MHC class I ligands.
    Saunders PM; Vivian JP; O'Connor GM; Sullivan LC; Pymm P; Rossjohn J; Brooks AG
    Immunol Rev; 2015 Sep; 267(1):148-66. PubMed ID: 26284476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.
    Bonaparte MI; Barker E
    Blood; 2004 Oct; 104(7):2087-94. PubMed ID: 15117765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
    Sullivan LC; Clements CS; Rossjohn J; Brooks AG
    Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
    Rouas-Freiss N; Moreau P; Menier C; LeMaoult J; Carosella ED
    Semin Cancer Biol; 2007 Dec; 17(6):413-21. PubMed ID: 17881247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
    Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
    Front Immunol; 2018; 9():1859. PubMed ID: 30140269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricking the balance: NK cells in anti-cancer immunity.
    Pahl J; Cerwenka A
    Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
    Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
    Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.